ArticleAesthetic plastic surgery2025
Facial Rejuvenation Strategy in Asian Women with Autologous Fat Transplantation.
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo explore the clinical strategy of autologous fat transplantation in facial rejuvenation.
methodsFrom September 2016 to May 2023, 2715 female patients with facial filling by autologous fat were retrospectively analysed. After treatment, they were followed up for 3-6 months to summarize the relationship between aesthetic design and treatment outcomes.
resultsIn total, 2306 patients were followed up and completed the questionnaires of satisfactory. Most patients (97%, 2237 cases) achieved satisfactory results after one operation, and about 3% (69 cases) achieved satisfactory results after secondary filling.
conclusionAutologous fat granule transplantation in the treatment of facial rejuvenation can achieve an excellent therapeutic outcome. Customized design according to the different lineaments, age, and other factors, and extensive use of various treatment methods can achieve better results. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
39496964What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.